Related Experiment Video
Updated: Jun 25, 2026

03:49
Enhanced Cochlear Coverage and Hearing Preservation in High-Frequency Hearing Loss via Electric Acoustic Stimulation with Longer Electrode
Published on: October 11, 2024
Feasibility study examining the short-term effects of Sonic Augmentation Technology™
Lourdes P Dale1, Audrey N Dana1, Carrie E Lee2
1Department of Psychiatry, College of Medicine-Jacksonville, University of Florida, Jacksonville, FL, United States.
Frontiers in Psychiatry
|June 24, 2026
Summary
Sonic Augmentation Technology™ (SAT) improved self-reported biobehavioral states, including relaxation and clarity. Individuals with higher baseline anxiety and autonomic reactivity experienced greater benefits from this novel auditory intervention.
Area of Science:
- Neuroscience
- Psychology
- Bioacoustics
Background:
- Sonic Augmentation Technology™ (SAT) is a novel auditory probe using acoustic features modeled on autonomic regulation patterns.
- The technology aims to influence self-reported biobehavioral states and physiological markers.
Purpose of the Study:
- To evaluate SAT's effectiveness in improving self-reported biobehavioral states.
- To assess if individuals with poorer baseline functioning benefit more from SAT.
- To investigate changes in endogenous oxytocin levels post-SAT.
Main Methods:
- Data collected from 113 participants (72 virtual, 41 in-person).
- Participants completed self-report measures for biobehavioral state, autonomic reactivity, anxiety, and depression.
- Salivary oxytocin levels measured pre- and post-SAT in in-person participants.
Main Results:
- Significant improvements observed in total biobehavioral state and arousal subscales post-SAT.
- Participants with higher autonomic reactivity, anxiety, and depression reported greater improvements.
- Increased salivary oxytocin levels were noted in the subset with available samples.
Conclusions:
- SAT shows potential as a cost-effective, non-invasive auditory intervention for enhancing well-being.
- The technology may be particularly beneficial for clinical populations with autonomic dysregulation, anxiety, and depression.
